Definitive Contract 75N95023C00016

Award Date 8/23/23
Potential Completion Date 8/22/28
Potential Value $9.7M
Contracting Federal Agency
National Institute on Drug Abuse
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Rockville, MD 20852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB) for AIDS research. The $7,442,369.52 contract does not have a set-aside designation. UTMB, a state-controlled institution of higher learning, serves as the prime contractor on this award. The contract supports basic research related to HIV/AIDS and other infectious diseases....
This is a definitive contract awarded by the National Institute of Mental Health (NIMH), a civilian agency, to the University of California, Los Angeles (UCLA) to collect, store, and provide clinical data and well-characterized biological specimens, including post-mortem tissue, from study volunteers and/or organ donors with HIV as well as HIV-negative controls. The contract, valued at $11,131,069.00, has a period of performance from August 23, 2023 to August 22, 2028. It is a cost-no-fee...
This federal contract award, valued at $10,000.00, was issued by the National Institute of Environmental Health Sciences (NIEHS) to the University of Texas Medical Branch at Galveston (UTMB), a major academic health center. The contract is for "Histopathology Assessment and snRNA Sample Preparation and Assessment," which suggests it involves research and analysis related to tissue samples and RNA sequencing. UTMB has extensive experience supporting federal agencies through numerous...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Texas Medical Branch at Galveston (UTMB). The $3,465,763 cost-reimbursement task order is part of a larger indefinite delivery contract (IDC) valued at $146.3 million that UTMB holds with NIAID to provide preclinical services for infectious disease research. Under this task order, UTMB will conduct studies...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the University of Texas Medical Branch at Galveston (UTMB). The contract, valued at $174,528.00, is a firm fixed-price delivery order with no set-aside designation. The contractor will extract historical raw data from all studies performed under previous indefinite delivery, indefinite quantity (IDIQ) contract mechanisms. This contract is part of a larger $146.3...
This is a federal contract award to the University of Texas Medical Branch at Galveston (UTMB), a major academic health center, from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The $6,069,874 definitive contract is for research and development facilities and does not have a set-aside designation. UTMB, a state-controlled institution of higher learning, has extensive experience supporting federal agencies in areas such...
This federal contract award is for the University of Texas Medical Branch at Galveston (UTMB) to provide a range of services related to biomedical research and healthcare to the National Institute of Allergy and Infectious Diseases (NIAID). The award is a Delivery Order under NIAID's Animal Models of Infectious Diseases 2010-2017 indefinite delivery contract, with a ceiling value of $1,508,894.41. The contract does not have a set-aside designation. As a major academic health center, UTMB has...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to the University of Texas Medical Branch at Galveston (UTMB). The $393,542.08 delivery order falls under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract supports UTMB's provision of pre-clinical research services, such as testing...
This federal contract award was issued by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to the University of Texas Medical Branch at Galveston (UTMB), a U.S. state government medical institution and educational institution. The $417,060 delivery order was for task order funding under the NIAID Preclinical Models of Infectious Diseases 2017-2024 Indefinite Delivery/Indefinite Quantity (IDIQ) contract, with a...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $1,151,741.00 delivery order contract to the University of Texas Medical Branch at Galveston (UTMB) for preclinical research services related to infectious diseases. This contract is a task order under the NIAID Preclinical Models of Infectious Diseases 2017-2024 indefinite delivery/indefinite quantity (IDIQ) contract. UTMB, a state controlled institution of...

This is a federal contract award by the National Institute of Mental Health (NIMH) to the University of Texas Medical Branch at Galveston (UTMB) to collect, store, and provide clinical data and biological specimens, including post-mortem tissue, from study volunteers and organ donors with and without HIV. The 5-year, $9,694,842.84 contract is a definitive, cost-no-fee contract and does not have a set-aside designation. UTMB, a state-controlled institution of higher learning, has extensive experience supporting federal agencies through research and development efforts, particularly in high-containment laboratory research and infectious disease modeling. The contract aligns with NIMH's strategic plans and scientific priorities to enhance neuroHIV biospecimen banking. It is part of the larger NIH National NeuroHIV Tissue Consortium, which includes a separately contracted data coordinating center.

Generated 6/26/25, 10:10 AM